| Date | Title | Description |
| 10.09.2026 | Sentea selected by SKF as fibre-optic sensing moves into industrial-scale deployment | Ghent, Belgium, 10 September 2026 − Sentea, the fibre-optic sensing specialist, has been selected by SKF, the world leader in bearings, as its partner to develop and produce the SKF Core, a new integrated hardware platform powering the next... |
| 11.08.2026 | Tanai Therapeutics appoints Josua Jordi as Chief Executive Officer | Ghent, Belgium, August 11th, 2026 – Tanai Therapeutics (“Tanai” or the “Company”), a VIB spin-off company developing small molecule therapies for obesity and cardiometabolic disease, today announced the appointment of Josua Jordi, Ph.D., as... |
| 10.08.2026 | Curium acquires Abscint SA | Original article on Curium website: Curium acquirs Abscint SA, expanding PET radiodiagnostic pipeline in oncology - Curium Pharma
Boston, MA and Liege, Belgium – 10 August, 2026 – Curium™ a leading global radiopharmaceutical company, announ... |
| 17.07.2026 | Qbic III provides pre-seed funding to Sightera Biosciences | ANTWERP, Belgium, July 17th 2026 - Sightera Biosciences, a tech-enabled biotech company and spin-off from the University of Antwerp and Antwerp University Hospital (UZA) using generative AI to design novel small molecules currently active i... |
| 06.07.2026 | MRM Health Strengthens Board | Ghent, Belgium – 25 June 2026 – MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, today announced the appointment of two experienced industry leaders to its Board of Directors as the Co... |
| 04.06.2026 | moveUP and Cascador Health Merge to Build a Data-Driven Digital Health Powerhouse | Brussels / Ghent, 3 June 2026 — Cascador Health and moveUP today announce the completion of their merger, creating critical mass by combining two digital health specialists. The combined company already works with 8 of the top 10 global pha... |
| 02.06.2026 | ABSCINT announced compelling clinical results for HER2-targeted imaging | Brussels, Liège– May 28, 2026 – ABSCINT, a clinical-stage molecular imaging company, today announced compelling clinical results for its novel HER2-targeted imaging agent, 68Ga-ABS011 PET/CT. Designed to enable whole-body, non-invasive asse... |
| 29.05.2026 | MRM Health awarded € 2.6M VLAIO Research Grant | Ghent, Belgium – May 28, 2026 – MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that it has bee... |
| 11.05.2026 | eyeo raises €40 million Series A | Eindhoven (Netherlands), May 11, 2026 – eyeo today announced it has raised €40 million in Series A funding, bringing eyeo’s total funding to €55 million. The round is led by Innovation Industries, with participation from existing investors ... |
| 04.05.2026 | MRM Health Granted FDA FAST Track designation for MH002 | Ghent, Belgium – April 30, 2026 – MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that MH002, t... |
| 02.12.2025 | AILOS Robotics raises €3.5 million in Seed Funding | Brussels, Belgium — 02 December 2025 — AILOS Robotics has secured €3.5 million in seed funding to industrialize a new class of actuation for modern, human-centric robots. With a patented gearbox that combines the agility and safety of quasi... |
| 28.11.2025 | Qbic III provides pre-seed funding to Innocens | *Originally published in Dutch. Translated into English for Qbic’s website.*
Antwerp, Belgium – November 27th, 2025 – Innocens raises €1.5 million to improve monitoring of premature babies and predict life-threatening infections
Neonatologi... |
| 27.11.2025 | Obulytix Strengthens Senior Leadership with Key Executive and Board Appointments | Ghent, Belgium – November 27th, 2025 – Obulytix, the biotechnology company pioneering Precision Lysin Therapeutics (PLTs) — a novel class of targeted biologics designed as next-generation antibiotics — today announces the appointment of Guy... |
| 04.09.2025 | MRM Health Raises €55 Million Series B | Ghent, Belgium – September 04, 2025 – MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million ... |
| 28.08.2025 | Spica Therapeutics secures € 1 Million VLAIO Grant to to advance macrophage-targeted therapies | Antwerp, Belgium - 27 August, 2025 - Spica Therapeutics, a pioneering biotech company focused on harnessing macrophage biology to develop transformative therapies across multiple disease areas, announced today that it has been awarded a €1.... |
| 28.08.2025 | VoxelSensors announces collaboration with Qualcomm Technologies | Brussels, Belgium, 28 August 2025 - VoxelSensors, a company developing novel intelligent sensing and data insights technology for Physical AI, today announced a collaboration with Qualcomm Technologies, Inc. to jointly optimize VoxelSensors... |
| 27.08.2025 | Citymesh partners with Accelleran to deploy commercial-grade 5G small cells in urban areas | Antwerp, Belgium - 26 August, 2025 - Citymesh and Accelleran are undertaking a joint trial of Open RAN technology to increase the density of 5G networks in urban environments. Starting with lab validation and moving into a large field trial... |
| 01.07.2025 | Animab Secures EUR 10 Million in Series B Financing | Zwijnaarde, 1 July 2025 – Animab (“the Company”), a leader in pioneering first-in-class oral antibody solutions for unmet needs in production animals, announces the successful closing of a EUR 10 million Series B funding round. The investme... |
| 25.06.2025 | Swave Photonics raises additional €6M Series A Funding from IAG Capital Partners and Samsung Ventures | Leuven (Belgium) & Silicon Valley - June 25, 2025 - Swave Photonics, the true holographic display company, today announced an additional €6M ($6.97M) in funding as part of a follow-on investment to the company's Series A round.
The fund... |
| 04.06.2025 | Spica Therapeutics closes € 10 Million seed round to advance macrophage-targeted therapies | Antwerp, Belgium – 4th June, 2025 – Spica Therapeutics (“Spica” or “the Company”), a pioneering biotech company transforming macrophage biology into breakthrough therapies, announced the successful closing of a €10 million Seed financing ro... |
| 13.05.2025 | Blue Foot Membranes appoints Carlos Campos as Chairman of the Board | Blue Foot’s foundation is built on trust, purpose, and a shared passion for making a meaningful impact. Today, the company is pleased to announce a leadership transition that highlights its ongoing commitment to growth and innovation.
Effec... |
| 07.05.2025 | Eyeo raises €15 million seed round to give cameras perfect eyesight | Eindhoven (Netherlands), May 7, 2025 – eyeo today announced it has raised €15 million in seed funding, co-led by imec.xpand, Invest-NL, joined by QBIC fund, High-Tech Gründerfonds (HTGF) and Brabant Development Agency (BOM). Eyeo revolution... |
| 29.04.2025 | Qbic III provides pre-seed funding to Rainbow Crops | Ghent, Belgium, 29 April 2025 – VIB proudly announces the launch of its latest spin-off, Rainbow Crops, a next-generation Agtech company focused on engineering complex, high-value agronomic traits that have long been difficult to address. T... |
| 23.04.2025 | Animab enters into an exclusive distribution agreement with Huvepharma | Zwijnaarde, Belgium, 22 April, 2025 - Animab (“the Company”), a leader in pioneering first-in-class oral antibody solutions for unmet needs in production animals, today announces an exclusive distribution agreement with Huvepharma® (“Huveph... |
| 13.03.2025 | moveUP to acquire Deep Structure.ai, strengthening AI-Driven Orthopedic Care | Brussels, Belgium – March 2025 – moveUP, a leading Belgian digital health company, is proud to announce that it has entered into an agreement to acquire Deep Structure.ai, a U.S.-based company pioneering AI-driven advancements in orthopedic... |
| 11.03.2025 | Aloxy raises €7.4 million from Dow Venture Capital, Emerson Ventures and existing investors to accelerate its global expansion | Antwerp, Belgium, March 2025 - Aloxy, a leading Internet of Things company offering innovative solutions for the chemical and energy industry, announces that it raised €7,4 million from Dow Venture Capital, Emerson Ventures and its existing... |
| 30.01.2025 | Qbic III provides pre-seed funding to Pleevi | Brussel, Belgium, 30 January 2025 – Electric vehicles (EVs) are on the rise, especially as company cars. Employees and visitors alike charge their cars on company premises. This charging is highly diverse: ranging from short to long periods... |
| 22.01.2025 | Tanai Therapeutics appoints Pieter Rottiers as Chief Executive Officer | Ghent, Belgium, 22 January 2025 – Tanai Therapeutics (“the Company” or “Tanai”), a VIB spin-off company developing a new therapeutic class of obesity treatments, today announces the appointment of Pieter Rottiers, as Chief Executive Officer... |
| 03.01.2025 | Swave Photonics raises €27M Series A Funding for the introduction of dynamic 3D holographic display products | Leuven (Belgium) & Silicon Valley - January 3, 2025 - Swave Photonics, the true holographic display company, today announced the close of its €27M ($28.27M) Series A funding round. This significant investment in Swave will catalyze the ... |
| 09.12.2024 | QustomDot secures EUR 2.7 million in financing to propel innovation and market growth | Ghent (Belgium), 26 November 2024 - QustomDot, a leading innovator in cadmium-free quantum dot technology for display applications, is pleased to announce the successful completion of a EUR 2.7 million financing round, accompanied by a EUR ... |
| 09.12.2024 | Belgian Health Data Company Cascador Health aims for European leadership with strategic acquisitions in immunology and neurology | Melle, 9 October 2024 - Cascador Health strengthens its market position in Europe with the acquisitions of Galenus Health and Neuroventis. Together, they contribute to improving healthcare in three of the fastest-evolving specializations—on... |
| 08.10.2024 | Obulytix appoints Dr. Kristof Van Emelen as Chief Executive Officer | Ghent, Belgium, October 1st 2024 – Obulytix, a pre-clinical stage biotech company pioneering phage lysin-based antibiotics to fight antibiotic-resistant infections, announces the appointment of Dr. Kristof Van Emelen as its new Chief Execut... |
| 25.09.2024 | Weavely raises €900K seed round to build interactive content with AI | Brussels, Belgium, 22 August 2024 - Weavely announces €900K seed round to build interactive content with AI.
At Weavely we develop a no-code platform that generates interactive content from digital designs. We have currently closed €900K in... |
| 25.09.2024 | Animab announces Jan Spaas as new Chairman of the Board | Zwijnaarde, Belgium – May 15, 2024: Animab, a front-runner in the field of highly innovative first-in-class oral antibody solutions for unmet needs in production animals, is excited to announce Jan Spaas joined the company’s board as Chairm... |
| 25.09.2024 | Blue Foot Membranes completes €15 Million Funding Round and appoints Carlos Campos as Independent Director | Lommel, Belgium, 02 July 2024 - Blue Foot Membranes NV ("Blue Foot"), a leading provider of unique backwashable ultrafiltration membranes for advanced water treatment solutions, proudly announces a total investment of €15 million ... |
| 25.09.2024 | Tanai Therapeutics secures additional financing from Novo Nordisk and BioGeneration Ventures for novel obesity drug | Ghent, Belgium, 19 September 2024 – Tanai Therapeutics (“the Company” or “Tanai”), a VIB spin-off company developing a new therapeutic class of obesity treatments, today announces it has secured additional financing from Novo Nordisk A/S an... |
| 10.09.2024 | MRM Health appoints Grégoire Franoux as Chief Business Officer and adds Ron Robison to its Board of Directors | GHENT, Belgium, September 10, 2024 – MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced the appointment of Grégoire Franoux, M.B.A., to ... |
| 24.04.2024 | Flindr raises €20 million in Series A | OSS, Netherlands, 24 April 2024 – Flindr Therapeutics B.V. (“Flindr” or “the Company”), a precision oncology therapeutics company, today announces a €20 million Series A financing to advance its pipeline of first-in-class, small molecule in... |
| 18.04.2024 | AmphiStar raises €6 million in Seed funding | Ghent, Belgium, April 18, 2024 - European Circular Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF) have joined forces to provide a significant boost to Ghent-based start-up AmphiStar. The funding round, led by ECBF, ra... |
| 07.02.2024 | VoxelSensors raises an additional €3 Million in Seed Extension | Brussels, Belgium, 30 January 2024 - VoxelSensors, a leading Belgian semiconductor deep tech start-up, closes its Seed Round with a €3 million in tail investment led by a new investor SFPIM Relaunch with participation from existing investor... |
| 07.02.2024 | Blue Foot Membranes raises €10 million round | Lommel, Belgium, 06 February 2024 - Blue Foot Membranes NV (“Blue Foot”), the provider of unique backwashable flat sheet membranes for MBR applications, announces the closing of a €10 million growth stage round, led by Circular Innovation F... |
| 06.12.2023 | Tanai Therapeutics raises € 2.85 million round in Seed funding | Ghent, 6 December 2023 – VIB, Flanders’ leading life sciences institute, together with lead investor V-Bio Ventures has launched a new spin-off company based on research at the VIB-UGent Center for Inflammation Research. With an initial see... |
| 06.12.2023 | Obulytix raises € 4 million round in Seed funding | Obulytix, a spin-off based on research results from Ghent University and KU Leuven, has built a platform that creates new ways to tackle bacterial infections. The innovative, phage lysin-based platform – leveraging the power of artificial i... |
| 26.09.2023 | ABSCINT raises € 3 million round to initiate Phase II Clinical Trials | Brussels, Liège, September 25, 2023 - ABSCINT has secured EUR 3 million for its technology platform that enables rapid targeting and visualisation of specific molecular markers throughout the entire body via a PET scan. ABSCINT is actively ... |
| 07.09.2023 | Axithra raises € 10 million in Seed funding | Leuven and Ghent (Belgium), 5 September, 2023 – Axithra, a new spin-off of imec and Ghent University, today announced a 10 million euro seed round, securing the first two years of R&D. Axithra develops a technology platform for therapeu... |
| 11.07.2023 | Aphea.bio raises a € 70 million Series C round | Gent, Belgium, 11 July 2023 – Aphea.Bio, a Belgium-based agricultural technology company, announced today the successful closing of its Series C Funding round, securing € 70 million. The round was led by Innovation Industries, joined by Kor... |
| 07.07.2023 | Final closing brings Qbic III to 88.5 million euros | St-Denijs-Westrem, Belgium, July, 5th 2023 – Qbic, the Belgian interuniversity venture capital fund that catalyzes the translation of promising technological developments from research institutions to sustainable companies, closes a second ... |
| 26.05.2023 | Qbic III co-leads VoxelSensors' Seed round | Brussels (Belgium), May 17, 2023 - VoxelSensors today announces an investment of €5M led by Belgian venture capital firms Capricorn Partners and Qbic, with participation from the investment firm finance&invest.brussels, existing investo... |
| 17.01.2023 | Qbic looking to strengthen its team | Are you passionate about innovation and early stage investing? Please take a look at the Career section of our website for further information! |
| 04.01.2023 | Indigo Diabetes Business Update | · SHINE clinical trial enrolment progressing well following positive results from the GLOW early feasibility trial |
| 05.12.2022 | ABSCINT raises new financing round | Brussels, Liège, December 5, 2022. ABSCINT is a clinical stage molecular imaging company that develops radiopharmaceutical diagnostics to guide patients and doctors to the right treatment at the right time. Its technology platform relies on... |
| 09.11.2022 | Qbic III leads Animab's Series A round | Ghent, November 7th, 2022 – Animab, a biotech start-up that is developing a new class of orally administered antibodies for animal health, is excited to announce the successful closing of its Series A round. The proceedings will be used to ... |
| 03.11.2022 | Qbic appoints Wim Van Camp as new Managing Partner | BELGIUM – Ghent, 3 November 2022 - Qbic Fund welcomes Wim Van Camp as new Managing Partner. Qbic was launched in 2012 as an inter-university initiative from Ghent University, VUB and University of Antwerp. Since then, the fund has expanded ... |
| 27.10.2022 | Indigo expands in the US and appoints Peter Devlin as President Indigo Medical US Inc. | BELGIUM – Ghent, 27 October 2022 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of Continuous Metabolite Monitoring (CMM™) devices utilising proprietary nanophotonics technology, today announces its expansion int... |
| 27.09.2022 | Qbic III provides pre-seed funding to weave.ly | Brussels, 30/09/2022- Brussels-based weave.ly, a new spin-off from the Vrije Universiteit Brussel, has completed an initial capital round of €300.000. Weave.ly is developing a pioneering no-code platform that allows for partial automation o... |
| 05.09.2022 | Qbic III leads THERAtRAME's Seed round | Liège, Belgium, 05 September 2022 – THERAtRAME SA has closed its first financing round of €4.5M to support the discovery and development of novel tRNA epitranscriptomics based cancer drugs through its AI-driven drug discovery platform. This... |
| 14.07.2022 | Qbic III invests in Swave | Swave Photonics, an innovator in Holographic eXtended Reality (HXR) technology to bring the metaverse to life, today announced a €7 million seed round. The investment will be used to fund the commercialization of truly realistic, immersive ... |
| 14.07.2022 | Qbic II leads Cascador Health's Series A round | Temse, 23 March 2022 - Belgian Cascador Health has just completed an important funding round. Together with the founders, Belgian parties Qbic, Volta Ventures and Theodorus and the Swiss healthcare provider Hirslanden AG are investing 3.4 m... |
| 14.07.2022 | Aloxy raises € 3.8M funding round | Antwerp, Belgium, June 2022 – Aloxy, a spin-off of imec and University of Antwerp, that develops plug-and-play Internet of Things technology for the chemical and energy industry, closes its next funding round. A consortium of investors, Ind... |
| 25.03.2022 | Qbic establishes third fund | St-Denijs-Westrem, Belgium, 17 March 2022 – Qbic, an inter-university venture capital fund focusing on the transformation of technological breakthroughs into sustainable businesses, announces the first close of its third fund at € 49 millio... |
| 16.03.2022 | Biogazelle acquired by CellCarta | MONTREAL, Canada, Dec 14, 2021 – CellCarta, a leading global provider of precision medicine laboratory services, announced today the acquisition of Biogazelle (“Biogazelle”), a leader in genomic testing solutions. Located in Ghent (Belgium)... |
| 16.03.2022 | Molecubes acquired by Bruker | November 19, 2021 - Ghent, Belgium -- Bruker Corporation (Nasdaq: BRKR) announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker’s po... |
| 16.03.2022 | Sentea raises € 2.3M to further grow its business | October 7th, 2021 - Sentea, a leading supplier of read-out systems for fiber optic sensor, announced to have successfully raised € 2.3 million to further expand its business. |
| 23.12.2021 | Qbic II leads seed round in Abscint | Brussels, Liège, Feb 10th 2021. A new VUB spin-off named ABSCINT NV was established. The spin-off is based on technology developed by the joint research efforts of the teams of Prof. Dr. Tony Lahoutte and Prof. Dr. Jo Van Ginderachter at VU... |
| 23.12.2021 | EyeD Pharma raises ⬠32M funding round | Liege, 22 December 2021 - The Liège-based pharmaceutical company, EyeD Pharma, received the backing of Belgian families, entrepreneurs active in the life sciences and public authorities to raise new funds. The €45 million raised will allow ... |
| 23.12.2021 | moveUP secures € 3.65M in financing round | moveUP has raised €3.65 million in order to continue its success story in Belgium and beyond. The financing round was co-led by Karista (France) and White Fund (Belgium), in an international consortium with Nina Capital (Spain), CAREvolutio... |
| 23.12.2021 | Qbic II leads CrowdScan's Series A round | Antwerp, 22 June 2021 - Crowdscan, the Belgian science-driven technology startup specialised in crowd analytics, has successfully completed its funding round. Its unique proposition, which comprises technology for accurate crowd management ... |
| 23.12.2021 | Trince raises ⬠4M with support of Qbic II | Ghent, Belgium, 4 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. This genetic modification of cells is essential in, for example, cell... |
| 21.12.2021 | Accelleran raises € 6.8M with support of Qbic II | As 5G network deployments accelerate across the globe and the OpenRAN system of standards gathers momentum, service providers from mobile operators to edge computing infrastructure providers to system integrators are turning to Accelleran’s... |
| 21.12.2021 | Aphea.bio closes its Series B round and raises ⬠18M in total | Gent, Belgium, April 14th, 2021 - The European Circular Bioeconomy Fund (ECBF) announces today its equity investment in Aphea.Bio, which thereby brings its Series B financing to a total of EUR 18 million. Aphea.Bio develops a new generation... |
| 21.12.2021 | Indigo Diabetes Initiates First Clinical Study | BELGIUM – Ghent, March 18, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, announces that its continuous multi-metabolite (‘CMM’) sensor has been successfully implant... |
| 21.12.2021 | PharmaFluidics acquired by Thermo Fisher Scientific | November 1, 2021 - Thermo Fisher Scientific announced its acquisition of PharmaFluidics: |
